FY 2025 Competitive Grant Solicitation Anti-Doping Activities
ID: 359018Type: Posted
Overview

Buyer

Office of National Drug Control Policy (ONDCP)

Award Range

$14M - $14M

Eligible Applicants

Nonprofits Without 501(c)(3) Status

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359018

Additional Information

https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=116728
Timeline
    Description

    The Office of National Drug Control Policy is inviting applications for the FY 2025 Competitive Grant Solicitation focused on Anti-Doping Activities. This grant aims to support initiatives that educate athletes about the dangers of drug use and work towards eliminating doping in amateur athletic competitions recognized by the United States Olympic & Paralympic Committee. The grant is particularly significant in promoting health and integrity in sports, with a funding amount set at $14 million for a single award. Interested applicants, specifically nonprofits without 501(c)(3) status, must submit their proposals by June 20, 2025, and can reach out to Grants.gov Customer Support at support@grants.gov for assistance.

    Point(s) of Contact
    support@grants.gov
    Files
    No associated files provided.
    Similar Opportunities
    Drug-Free Communities (DFC) Support Program – NEW (Year 1)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Drug-Free Communities (DFC) Support Program grants for Fiscal Year 2026, aimed at preventing youth substance use. This program seeks to establish and strengthen collaborations among community coalitions, public and private non-profit agencies, and government entities to reduce substance abuse among youth and, over time, among adults by addressing community risk factors. The DFC Support Program is critical for fostering safe and healthy communities, with an estimated total funding of $31,250,000 available for approximately 50 awards, each ranging from $0 to $125,000. Interested applicants, particularly community-based coalitions that have not previously received a DFC grant, must submit their applications electronically by April 14, 2026, with awards expected to be announced by August 31, 2026. For further inquiries, applicants can contact Christi Jones at DFCNOFO@cdc.gov.
    Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)." This initiative aims to support educational activities that promote diversity in the biomedical and behavioral sciences, particularly focusing on substance use and addiction research, by encouraging applications from institutions committed to underrepresented groups. The program seeks to develop a diverse pool of researchers through mentorship and educational activities tailored to various career stages, with a budget request limit of $250,000 in direct costs annually for up to five years. Interested applicants must submit their proposals by 5:00 PM local time on November 13, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)" aimed at supporting research into effective interventions for substance use disorders (SUDs) and overdose. This cooperative agreement encourages applications for preclinical and clinical studies focusing on pharmacotherapies, device-based treatments, digital therapeutics, and behavioral interventions, with the goal of advancing these interventions towards regulatory approval or clinical adoption. The funding amount can reach up to $3 million, and applications are due by 5:00 PM local time, with multiple submission cycles from October 2025 to August 2028. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Research Education Program for Clinical Researchers and Clinicians under Funding Opportunity Number PAR-25-204, aimed at enhancing the training of clinicians and clinical researchers in substance use disorder (SUD) research. This program seeks to address the shortage of qualified professionals in the field by supporting educational activities that develop skills and provide hands-on research experiences, particularly targeting underrepresented groups in the workforce. With a budget of up to $350,000 annually for a project duration not exceeding five years, the program is open for applications starting February 11, 2025. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) aimed at supporting research for the development of medications to prevent and treat substance use disorders (SUDs) and overdose. This initiative will focus on preclinical and clinical research studies that can rapidly advance candidate interventions toward regulatory approval or clinical adoption, encouraging collaborative efforts among experts in various fields such as pharmacology, toxicology, and clinical trials. While applications are not currently being solicited, interested small businesses are encouraged to begin forming partnerships and developing projects in anticipation of the opportunity, with an estimated synopsis post date of August 15, 2025, and a projected award date of July 1, 2026. For further inquiries, potential applicants can contact Drew Townsend, Ph.D., at drew.townsend@nih.gov or by phone at 301-443-4577.
    Comprehensive Addiction and Recovery Act (CARA)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering grants under the Comprehensive Addiction and Recovery Act (CARA) to support community-based coalitions addressing the crises of opioid, methamphetamine, and prescription drug misuse among youth aged 12-18. Eligible applicants include nonprofit organizations, state and local governments, and other entities that have documented higher-than-average rates of substance misuse, specifically those that are current or former recipients of the Drug-Free Communities (DFC) Support Program. This initiative aims to enhance coalition activities to prevent and reduce substance use among American youth, with a total estimated funding of $16,875,000 available for approximately 45 awards, each ranging from $0 to $75,000. Interested parties should submit their applications electronically by March 16, 2026, and can direct inquiries to Christi Jones at CARANOFO@cdc.gov.
    Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Chemical Countermeasures Research Program (CCRP) Initiative, aimed at supporting research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, such as fentanyl and carfentanil. This initiative seeks to advance understanding of both immediate and delayed health impacts associated with these substances, emphasizing innovative research into toxicity mechanisms and the development of new therapeutic strategies. The program will provide up to four grants, with a maximum award of $300,000 annually over a potential five-year period, totaling an estimated $2 million in funding. Interested applicants, including various educational and nonprofit institutions, must submit their proposals by November 18, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity titled "NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity," which aims to support research initiatives that address the intersection of substance use and racial equity. This grant program, utilizing the DP1 activity code, is designed to foster meaningful collaborations and innovative projects in this critical area of health research. With an estimated total program funding of $3.5 million and an award ceiling of $700,000, the anticipated application period will open in Fall 2025, following the expected publication of the notice of funding opportunity in Spring 2025. Interested applicants should prepare to submit their proposals by the estimated closing date of October 14, 2025, with awards expected to be made by July 1, 2026.
    Drug-Free Communities (DFC) Support Program – COMPETING CONTINUATION (Year 6)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Drug-Free Communities (DFC) Support Program – Competing Continuation (Year 6) grant, aimed at supporting community-based coalitions in their efforts to prevent and reduce youth substance use. Eligible applicants include organizations that have previously received DFC funding and are either resuming after a lapse or applying for a second five-year funding cycle, with a focus on collaboration among various community sectors to promote a drug-free environment. This grant opportunity, with an estimated total funding of $31.25 million and an award ceiling of $125,000, is critical for addressing substance use issues among youth and will accept applications until April 14, 2026. Interested parties can reach out to Christi Jones at DFCNOFO@cdc.gov for further information.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Substance Use/Substance Use Disorder Dissertation Research Award (R36), aimed at supporting doctoral candidates for up to two years in their dissertation research related to substance use disorders. This grant, under the National Institute on Drug Abuse (NIDA), encourages applications from diverse backgrounds and focuses on advancing knowledge in prevention, diagnosis, and treatment of substance misuse and related health outcomes, excluding independent clinical trials. Eligible applicants can receive up to $50,000 per year for innovative research aligned with NIDA’s strategic plan, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.